Given our findings on the effects of Runx2 on period length, it would be worthwhile to assess the status of circadian biomarkers and sleep patterns in individuals with CCD to determine if the effects of Runx2 haplodeficiency we observed in mice translate to humans. The gene discussed is RUNX2; the disease is cleidocranial dysplasia 1.